IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 214 filers reported holding IMMUNOMEDICS INC in Q3 2018. The put-call ratio across all filers is 1.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $46,809,000 | +33.3% | 1,320,782 | -49.3% | 0.03% | +8.3% |
| Q1 2020 | $35,123,000 | -55.2% | 2,605,570 | -29.6% | 0.02% | -40.0% |
| Q4 2019 | $78,348,000 | +49.8% | 3,702,664 | -6.1% | 0.04% | +42.9% |
| Q3 2019 | $52,304,000 | -4.7% | 3,944,509 | -0.3% | 0.03% | -6.7% |
| Q2 2019 | $54,874,000 | -25.5% | 3,956,289 | +3.2% | 0.03% | -26.8% |
| Q1 2019 | $73,611,000 | +34.2% | 3,831,902 | -0.3% | 0.04% | +17.1% |
| Q4 2018 | $54,838,000 | -27.7% | 3,842,894 | +5.6% | 0.04% | -14.6% |
| Q3 2018 | $75,827,000 | -0.4% | 3,640,299 | +13.1% | 0.04% | -4.7% |
| Q2 2018 | $76,164,000 | +169.6% | 3,217,759 | +66.4% | 0.04% | +152.9% |
| Q1 2018 | $28,248,000 | +15.1% | 1,933,456 | +27.3% | 0.02% | +13.3% |
| Q4 2017 | $24,536,000 | – | 1,518,335 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 17,714,461 | $368,992,000 | 16.94% |
| ACUTA CAPITAL PARTNERS, LLC | 2,055,500 | $42,816,000 | 15.27% |
| Foresite Capital Management III, LLC | 2,691,729 | $56,069,000 | 12.37% |
| Foresite Capital Management IV, LLC | 1,231,543 | $25,653,000 | 8.41% |
| NEXTHERA CAPITAL LP | 1,398,577 | $29,132,000 | 5.58% |
| Palo Alto Investors LP | 5,013,764 | $104,437,000 | 4.22% |
| Ghost Tree Capital, LLC | 883,823 | $18,410,000 | 3.91% |
| First Light Asset Management, LLC | 1,151,622 | $23,988,000 | 3.87% |
| DLD Asset Management, LP | 3,403,000 | $70,918,000 | 3.51% |
| RA Capital Management | 3,119,778 | $64,985,000 | 3.47% |